+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Fluorides 691868-88-9
691868-88-9,MFCD03102493
Catalog No.:AA00G1Z5

691868-88-9 | 8-(1,3,4-OXADIAZOL-2-YL)-2,4-BIS(TRIFLUOROMETHYL)IMIDAZO[1,2-A][1,8]NAPHTHYRIDINE

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
≥98%
in stock  
$46.00   $32.00
- +
250mg
90%
in stock  
$110.00   $77.00
- +
1g
90%
in stock  
$304.00   $213.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00G1Z5
Chemical Name:
8-(1,3,4-OXADIAZOL-2-YL)-2,4-BIS(TRIFLUOROMETHYL)IMIDAZO[1,2-A][1,8]NAPHTHYRIDINE
CAS Number:
691868-88-9
Molecular Formula:
C14H5F6N5O
Molecular Weight:
373.2128
MDL Number:
MFCD03102493
SMILES:
FC(c1nc2n3cc(nc3ccc2c(c1)C(F)(F)F)c1nnco1)(F)F
Properties
Computed Properties
 
Complexity:
531  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
26  
Hydrogen Bond Acceptor Count:
11  
Rotatable Bond Count:
1  
XLogP3:
3.7  

Downstream Synthesis Route

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2013/59559,2013,A2

[2]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2022/49521,2022,A1

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2013/59559,2013,A2Locationinpatent:Page/Pagecolumn00188

[2]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2022/49521,2022,A1Locationinpatent:Page/Pagecolumn50

[3]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2022/49521,2022,A1Locationinpatent:Page/Pagecolumn50

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2013/59559,2013,A2

[2]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2022/49521,2022,A1

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2013/59559,2013,A2Locationinpatent:Paragraph00221

[2]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2022/49521,2022,A1Locationinpatent:Page/Pagecolumn58

[3]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2022/49521,2022,A1Locationinpatent:Page/Pagecolumn58

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2013/59559,2013,A2Locationinpatent:Paragraph00204

[2]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2022/49521,2022,A1Locationinpatent:Page/Pagecolumn54

[3]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2022/49521,2022,A1Locationinpatent:Page/Pagecolumn54

Literature

Title: Design and synthesis of imidazo[1,2-α][1,8]naphthyridine derivatives as anti-HCV agents via direct C-H arylation.

Journal: Organic & biomolecular chemistry 20140421

Title: Hideyuki Konishi, et al. An Orally Available, Small-Molecule Interferon Inhibits Viral Replication. Sci Rep. 2012;2:259.

Title: Yutaka Furutani, et al. An interferon-like small chemical compound CDM-3008 suppresses hepatitis B virus through induction of interferon-stimulated genes. PLoS One. 2019 Jun 12;14(6):e0216139.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 691868-88-9
Building Blocks
More >
Tags:691868-88-9 Molecular Formula|691868-88-9 MDL|691868-88-9 SMILES|691868-88-9 8-(1,3,4-OXADIAZOL-2-YL)-2,4-BIS(TRIFLUOROMETHYL)IMIDAZO[1,2-A][1,8]NAPHTHYRIDINE